Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To report frequencies of gestational diabetes mellitus (GDM) among the 15 centers that participated in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study using the new International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria. RESEARCH DESIGN AND METHODS: All participants underwent a 75-g oral glucose tolerance test between 24 and 32 weeks’ gestation. GDM was retrospectively classified using the IADPSG criteria (one or more fasting, 1-h, or 2-h plasma glucose concentrations equal to or greater than threshold values of 5.1, 10.0, or 8.5 mmol/L, respectively). RESULTS: Overall frequency of GDM was 17.8% (range 9.3–25.5%). There was substantial center-to-center variation in which glucose measures met diagnostic thresholds. CONCLUSIONS: Although the new diagnostic criteria for GDM apply globally, center-to-center differences occur in GDM frequency and relative diagnostic importance of fasting, 1-h, and 2-h glucose levels. This may impact strategies used for the diagnosis of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The one-step approach has more than doubled the incidence of GDM, but its clinical benefit in reducing adverse pregnancy outcomes remains controversial.”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This one-step strategy was anticipated to signi fi cantly increase the incidence of GDM (from 5 -6% to 15 -20%), primarily because only one abnormal value, not two, became suf fi cient to make the diagnosis (208).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [208]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This one-step strategy was anticipated to significantly increase the incidence of GDM (from 5-6% to 15-20%), primarily because only one abnormal value, not two, became sufficient to make the diagnosis (191).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [191]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This increase in the number of GDM cases occurred, due to the fact that only one elevated value is required to make the diagnosis [45].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“According to a global observational study, the prevalence of GDM ranged between 9% and 26% in 15 centres51.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [51]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Self-citationHyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702
Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group
(2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318187b7a2 · Cited by 488
Mårdh, P.-A., Paavonen, J. A., & Puolakkainen, M. H. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0719-8_18 · Cited by 26
Cited by
Items 201–300 of 817
Madhloum, N., Nawrot, T. S., Gyselaers, W., Roels, H. A., Bijnens, E. M., Vanpoucke, C., Lefebvre, W., Janssen, B. G., & Cox, B. (2019) · Environment International · doi:10.1016/j.envint.2019.05.047 · Cited by 41
Low-Carbohydrate Diets for Gestational Diabetes
Farabi, S. S., & Hernandez, T. L. (2019) · Nutrients · doi:10.3390/nu11081737 · Cited by 42
One-step or 2-step testing for gestational diabetes: which is better?
Coustan, D. R., Dyer, A. R., & Metzger, B. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.009 · Cited by 40
Self-citationUpadhyaya, B., Larsen, T., Barwari, S., Louwagie, E., Baack, M., & Dey, M. (2017) · Nutrients · doi:10.3390/nu9040407 · Cited by 40
Papachatzopoulou, E., Chatzakis, C., Lambrinoudaki, I., Panoulis, K., Dinas, K., Vlahos, N., Sotiriadis, A., & Eleftheriades, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108048 · Cited by 40
Jin, S., Sha, L., Dong, J., Yi, J., Liu, Y., Guo, Z., & Hu, B. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6062478 · Cited by 40
“5% of pregnant women, and its incidence is continuing to increase [2].”
BackgroundWeinert, L. S., Mastella, L. S., Oppermann, M. L. R., Silveiro, S. P., Guimarães, L. S. P., & Reichelt, A. J. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003069 · Cited by 40
Counterpoint: Establishing Consensus in the Diagnosis of GDM Following the HAPO Study
McIntyre, H. D., Metzger, B. E., Coustan, D. R., Dyer, A. R., Hadden, D. R., Hod, M., Lowe, L. P., Oats, J. J. N., & Persson, B. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0497-x · Cited by 40
Self-citationImpact des nouveaux critères de dépistage sur la prévalence du diabète gestationnel
Wery, E., Vambergue, A., Gouëff, F. L., Vincent, D., & Deruelle, P. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.01.005 · Cited by 40
Cheuk, Q. K., Lo, T., Wong, S., & Lee, C. (2015) · Hong Kong Medical Journal · doi:10.12809/hkmj144470 · Cited by 40
Pharmacological Management of Gestational Diabetes Mellitus
Mukerji, G., & Feig, D. S. (2017) · Drugs · doi:10.1007/s40265-017-0807-0 · Cited by 40
Programming of Vascular Dysfunction in the Intrauterine Milieu of Diabetic Pregnancies
Sallam, N. A., Palmgren, V. A. C., Singh, R. D., John, C. M., & Thompson, J. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113665 · Cited by 40
“According to these new criteria, worldwide prevalence is 18%, ranging from 9 to 25% depending on the population studied [3].”
BackgroundSocio‐economic status and risk of gestational diabetes mellitus among Chinese women
Song, L., Shen, L., Li, H., Liu, B., Zheng, X., Zhang, L., Xu, S., & Wang, Y. (2017) · Diabetic Medicine · doi:10.1111/dme.13415 · Cited by 39
The Maternal Microbiome and Gestational Diabetes Mellitus: Cause and Effect
Dias, S. C., Pheiffer, C., & Adam, S. (2023) · Microorganisms · doi:10.3390/microorganisms11092217 · Cited by 39
“The prevalence of gestational diabetes mellitus (GDM), defined as glucose intolerance that develops during pregnancy [1,2], is on the rise globally.”
O'Reilly, S. L. (2014) · Healthcare · doi:10.3390/healthcare2040468 · Cited by 39
Mukerji, G., Kainth, S., Pendrith, C., LOWE, J. M., Feig, D. S., Banerjee, A., Wu, W., & Lipscombe, L. L. (2015) · Diabetic Medicine · doi:10.1111/dme.13009 · Cited by 39
Gestational Diabetes Mellitus: Is It Time to Reconsider the Diagnostic Criteria?
Cheung, N. W., & Moses, R. G. (2018) · Diabetes Care · doi:10.2337/dci18-0013 · Cited by 35
Soliman, A. T., Salama, H., Rifai, H. A., Sanctis, V. D., Al-Obaidly, S., Qubasi, M. A., & Olukade, T. O. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89is4.7356 · Cited by 34
Todi, S., Sagili, H., & Kamalanathan, S. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05564-9 · Cited by 39
High probability of false-positive gestational diabetes mellitus diagnosis during early pregnancy
Nakanishi, S., Aoki, S., Kasai, J., Shindo, R., Obata, S., Hasegawa, Y., Mochimaru, A., & Miyagi, E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001234 · Cited by 37
Quaresima, P., Visconti, F., CHIEFARI, E. D., Mirabelli, M., Borelli, M., Caroleo, P., FOTI, D. P., Puccio, L., Venturella, R., Carlo, C. D., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5393952 · Cited by 39
The association between gestational diabetes and stillbirth: a systematic review and meta-analysis
Lemieux, P., Benham, J. L., Donovan, L., Moledina, N., Pylypjuk, C. L., & Yamamoto, J. M. (2021) · Diabetologia · doi:10.1007/s00125-021-05579-0 · Cited by 39
Microbiome and Gestational Diabetes: Interactions with Pregnancy Outcome and Long-Term Infant Health
Neri, C., Serafino, E., Morlando, M., & Familiari, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9994734 · Cited by 39
“Gestational diabetes mellitus (GDM) is an increasing public health concern that affects approximately 5-20% of pregnancies, and its prevalence is progressively rising [10, 11].”
BackgroundWindows of Opportunity for Lifestyle Interventions to Prevent Gestational Diabetes Mellitus
Phelan, S. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1586504 · Cited by 38
Raab, R., Geyer, K., Zagar, S., & Hauner, H. (2023) · Journal of Medical Internet Research · doi:10.2196/48853 · Cited by 39
IL-34 causes inflammation and beta cell apoptosis and dysfunction in gestational diabetes mellitus
Piao, C., Wang, X., Peng, S., Guo, X., Zhao, H., Li, H., Zeng, Y., Zhang, F., Zhu, K., & Wang, Y. (2019) · Endocrine Connections · doi:10.1530/ec-19-0436 · Cited by 38
Nguyen‐Ngo, C., Willcox, J. C., & Lappas, M. (2020) · Placenta · doi:10.1016/j.placenta.2020.08.002 · Cited by 38
Madsen, L. R., GIBBONS, K. S., Ronald, C. W., Tam, W. H., Catalano, P. M., Sacks, D. A., LOWE, J. M., & McIntyre, D. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05323-0 · Cited by 38
“2% fulfilled the IADPSG criteria for GDM, which was comparable with the total HAPO cohort [20].”
ResultSelf-citationShahbazian, H., Nouhjah, S., Shahbazian, N., Jahanfar, S., Latifi, S. M., Aleali, A., Shahbazian, N., & Saadati, N. (2016) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.019 · Cited by 37
Mora-Ortiz, M., & Rivas‐García, L. (2024) · Open Research Europe · doi:10.12688/openreseurope.18026.1 · Cited by 38
Inthavong, S., Jatavan, P., & Tongsong, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111666 · Cited by 37
Chi, C., Loy, S. L., Chan, S., Choong, C., Cai, S., Soh, S., Tan, K. H., Yap, F. K. P., Gluckman, P. D., Godfrey, K. M., et al. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1707-3 · Cited by 37
“In addition, differences in GDM prevalence and in the relative diagnostic importance of FPG, 1-h PG and 2-h PG were observed across the geographically-diverse centres of the HAPO study [10].”
BackgroundResultInfluentialÖztürk, F. Y., & Altuntaş, Y. (2015) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.5350/semb.20150317014238 · Cited by 36
Helseth, R., Salvesen, Ø., Stafne, S. N., Mørkved, S., Salvesen, K. A., & Carlsen, S. M. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.928942 · Cited by 30
Screening for gestational diabetes in Europe: where do we stand and how to move forward?
Benhalima, K., Damm, P., Assche, A. V., Mathieu, C., Devlieger, R., Mahmood, T. A., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.002 · Cited by 36
Hernandez, T. L. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.2.82 · Cited by 35
“There is hope that optimal nutrition therapy can offer a lower-cost treatment strategy for the rising number of women with GDM, which is anticipated to encompass 18% of all pregnancies after new diagnostic criteria are adopted (6,7).”
BackgroundYeung, R. O., Savu, A., Kinniburgh, B. A., Lee, L., Dzakpasu, S., Nelson, C. R. M., Johnson, J. A., Donovan, L., Ryan, E. A., & Kaul, P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.016 · Cited by 36
Qin, S., Wang, Y., Wang, S., Ning, B., Huai, J., & Yang, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.870422 · Cited by 35
Factors influencing lifestyle behaviours during and after a gestational diabetes mellitus pregnancy
Tierney, M., O'Dea, A., Danyliv, A., Noctor, E., McGuire, B., Glynn, L., Al-Imari, H., & Dunne, F. (2015) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2015.1073111 · Cited by 30
“Health Psychology and Behavioral Medicine, 2015 Vol. 3, No. 1, 204–216, http://dx.doi.org/10.1080/21642850.2015.1073111 9.3–25.5% internationally (Sacks et al., 2012) and 12.4% in Ireland (O’Sullivan et al., 2011).”
InfluentialUnresolved controversies in gestational diabetes: implications on maternal and infant health
Barbour, L. A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000080 · Cited by 26
Genetic Risk Factors and Gene–Lifestyle Interactions in Gestational Diabetes
Jääskeläinen, T. J., & Klemetti, M. M. (2022) · Nutrients · doi:10.3390/nu14224799 · Cited by 35
“However, reflecting the multifaceted role of environmental and genetic factors in GDM pathogenesis, as well as the prevailing lack of global consensus on diagnostic criteria, internationally reported rates vary widely [3,4].”
BackgroundDifferent intensities of glycaemic control for women with gestational diabetes mellitus
Hofer, O. J., Martis, R., Alsweiler, J. M., & Crowther, C. A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011624.pub3 · Cited by 34
Berntorp, K. E., Anderberg, E., Claesson, R., Ignell, C., & Källén, K. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0722-x · Cited by 34
Perspectives on the Proposed Gestational Diabetes Mellitus Diagnostic Criteria
Langer, O., Umans, J. G., & Miodovnik, M. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31827711e5 · Cited by 34
“5%) in GDM prevalence.(29) Recent reports have echoed this variation in prevalence, suggesting that GDM would be diagnosed in 12.”
BackgroundComparison of Two Screening Strategies for Gestational Diabetes (GDM 2 ) Trial: Design and rationale
Abebe, K. Z., Scifres, C., Simhan, H. N., Day, N. L., Catalano, P. M., Bodnar, L. M., Costacou, T., Matthew, D., Illes, A., Orris, S. R., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.08.012 · Cited by 34
“AC CE PT ED M AN US CR IP T 18%,[11] resulting in increased medical interventions, risk of iatrogenic complications, and cost of care.”
Adiponectin Promotes Maternal β-Cell Expansion Through Placental Lactogen Expression
Admin, A., Qiao, L., Saget, S., Lu, C., Hay, W. W., Karsenty, G., & Shao, J. (2020) · Diabetes · doi:10.2337/db20-0471 · Cited by 33
Ott, R., Stupin, J. H., Loui, A., Eilers, E., Melchior, K., Rancourt, R. C., Schellong, K., Ziska, T., Dudenhausen, J. W., Henrich, W., et al. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1889-8 · Cited by 33
Bishay, R. H., & Greenfield, J. R. (2017) · The Medical Journal of Australia · doi:10.5694/mja16.01467 · Cited by 33
Gestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
for the Target Study Group, Crowther, C. A., Alsweiler, J. M., Hughes, R., & Brown, J. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2060-2 · Cited by 31
Self-citationTarrant, M., Chooniedass, R., Fan, H. S. L., Buono, K. D., & Masina, S. (2020) · Journal of Human Lactation · doi:10.1177/0890334420950259 · Cited by 31
“…of GDM, and recent reviews of GDM rates using up- to- date and more inclusive diagnostic criteria (International Association of Diabetes and Pregnancy Study Groups Consensus Panel., 2010), estimate the global prevalence to be around 17.8%, with a range from 9.3% to 25.5% (Sacks et al., 2012).”
MethodInfluentialRegnault, N., Lebreton, E., Tang, L., Fosse‐Edorh, S., Barry, Y., Olié, V., Billionnet, C., Weill, A., Vambergue, A., & Cosson, E. (2024) · Diabetologia · doi:10.1007/s00125-023-06066-4 · Cited by 31
Gestational Diabetes Diagnostic Methods (GD2M) Pilot Randomized Trial
Scifres, C., Abebe, K. Z., Jones, K. A., COMER, D. M., Costacou, T., Freiberg, M. S., Simhan, H. N., Day, N. L., & Davis, E. M. (2014) · Maternal and Child Health Journal · doi:10.1007/s10995-014-1651-4 · Cited by 31
“The American Diabetes Association endorsed these recommendations in 2011 [6], and the newly recommended diagnostic criteria are expected to increase the prevalence of GDM to approximately 18 % of pregnant women [7].”
MethodMcIntyre, D. H. (2018) · Diabetes Care · doi:10.2337/dci17-0056 · Cited by 31
Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence
Kuo, C., & Li, H. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1271-x · Cited by 31
Vascular Complications of Diabetes Mellitus
Chiong, Y., & Evans‐Molina, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-37078-6_49 · Cited by 31
The proposed GDM diagnostic criteria: a difference, to be a difference, must make a difference
Langer, O., Umans, J. G., & Miodovnik, M. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.734874 · Cited by 31
The post-HAPO situation with gestational diabetes: the bright and dark sides
Lapolla, A., & Metzger, B. E. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1146-7 · Cited by 30
Self-citationFang, C., Gan, Y., Li, Y., He, W., Wu, W., Wang, K., & Li, Q. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02207-0 · Cited by 30
Hou, G., Gao, Y. M., Poon, L. C., Ren, Y., Zeng, C., Wen, B., Syngelaki, A., Lin, L., Zi, J., Su, F., et al. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17297 · Cited by 30
Cosson, E., Bihan, H., Reach, G., Vittaz, L., Carbillon, L., & Valensi, P. E. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007120 · Cited by 30
“Cosson E, et al. BMJ Open 2015;5:e007120. doi:10.1136/bmjopen-2014-007120 1 with onset or first recognition during pregnancy and is now very common, with a prevalence ranging from 9.3% in Israel to 25.5% in California, USA.21 Although GDM is also more frequent in cases of psychosocial deprivation,18 19 22 23 its progn…”
BackgroundInfluentialMolecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models
Bhalla, P., Wysocki, C., & van Oers, N. S. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00830 · Cited by 30
Pregnancy Reveals Evolving Risk for Cardiometabolic Disease in Women
Ferranti, E. P., Jones, E. J., & Hernandez, T. L. (2016) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2016.02.004 · Cited by 30
Economic evaluations of gestational diabetes mellitus screening: a systematic review
Mo, X., Gai Tobe, R., Takahashi, Y., Arata, N., Liabsuetrakul, T., Nakayama, T., & Mori, R. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20190338 · Cited by 29
Grunnet, L. G., Hjort, L., Minja, D. T. R., Msemo, O. A., Møller, S. L., Prasad, R. B., Groop, L., Lusingu, J., Nielsen, B. B., Schmiegelow, C., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093109 · Cited by 29
“Interestingly, when frequencies of GDM were reported among the 15 centres that participated in the Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study, a substantial centre-to-centre variation was found in which the time-point of glucose measures met the diagnostic threshold for GDM [27].”
BackgroundHanna, F. W., Duff, C. J., Shelley-Hitchen, A., Hodgson, E., & Fryer, A. A. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-2-108 · Cited by 22
Gestational diabetes risk in a multi-ethnic population
Jaffe, A., Giveon, S. M., Rubin, C., Novikov, I., Ziv, A., & Kalter‐Leibovici, O. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01404-8 · Cited by 29
Cremona, A., Saunders, J. A., Cotter, A. M., Hamilton, J. K., Donnelly, A., & O’Gorman, C. S. (2019) · European Journal of Pediatrics · doi:10.1007/s00431-019-03554-x · Cited by 29
Glycated albumin is an optimal biomarker for gestational diabetes mellitus
Huang, Y., Hu, Y., MA, Y., & Ye, G. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2808 · Cited by 29
Gestational Diabetes - Causes, Diagnosis and Treatment
Sobrevía, L. (2013) · InTech eBooks · doi:10.5772/46133 · Cited by 29
Mendoza, L. C., Harreiter, J., Simmons, D. S., Desoyé, G., Adelantado, J. M., Juarez, F., Chico, A. I., Devlieger, R., Assche, A. V., Galjaard, S., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0003 · Cited by 28
Huhn, E. A., Linder, T., Eppel, D., Weißhaupt, K., Klapp, C., Schellong, K., Henrich, W., Yerlikaya‐Schatten, G., Rosicky, I., Husslein, P. W., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040498 · Cited by 28
A new predictive tool for the early risk assessment of gestational diabetes mellitus
Capula, C., CHIEFARI, E. D., Borelli, M., Oliverio, R., Vero, A., FOTI, D. P., Puccio, L., Vero, R., & Brunetti, A. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.05.004 · Cited by 28
“[22] D.”
Koivunen, S., Torkki, A., Bloigu, A. H., Gissler, M., Pouta, A. M., Kajantie, E., & Vääräsmäki, M. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13030 · Cited by 28
Oral glucose tolerance test results in early pregnancy: A Finnish population-based cohort study
Jokelainen, M., Stach‐Lempinen, B., Rönö, K., Nenonen, A., Kautiainen, H., Teramo, K. A., & Klemetti, M. M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108077 · Cited by 28
Göbl, C. S., Bozkurt, L., Rivic, P., Schernthaner, G.-H., Weitgasser, R., Pacini, G., Mittlböck, M., Bancher‐Todesca, D., Lechleitner, M., & Kautzky‐Willer, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2726-7 · Cited by 28
Performance of early risk assessment tools to predict the later development of gestational diabetes
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Mittlböck, M., Yerlikaya‐Schatten, G., Schatten, C., Husslein, P., Eppel, W., Huhn, E. A., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13630 · Cited by 27
Popova, P., Isakov, A. O., Rusanova, A. N., Sitkin, S. I., Anopova, A. D., Vasukova, E. A., Tkachuk, A., Nemikina, I. S., Stepanova, E. A., Eriskovskaya, A. I., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00650-9 · Cited by 27
“Gestational diabetes mellitus (GDM) represents a prevalent condition, impacting a substantial portion, approximately up to 9 – 26%, of pregnancies 1 .”
Bartáková, V., Kollarova, R., Kuricová, K., Šebeková, K., Bělobrádková, J., & Kaňková, K. (2015) · Biomedical Papers · doi:10.5507/bp.2015.045 · Cited by 27
Benhalima, K., Verstraete, S., Muylle, F., Decochez, K., Devlieger, R., Crombrugge, P. V., Verhaegen, A. A., Wens, J., & Mathieu, C. (2017) · International Journal of Endocrinology · doi:10.1155/2017/3971914 · Cited by 27
“Using the 2013 WHO criteria, GDM prevalence increases significantly in most populations and affects 9–35% of pregnancies [6, 7].”
MethodShould the IADPSG criteria be applied when diagnosing early-onset gestational diabetes?
Hagiwara, Y., Kasai, J., Nakanishi, S., Saigusa, Y., Miyagi, E., & Aoki, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.048 · Cited by 24
The Initial Oral Microbiota of Neonates Among Subjects With Gestational Diabetes Mellitus
He, Z., Wu, J., Xiao, B., Xiao, S., Li, H., & Wu, K. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00513 · Cited by 27
Gestational Diabetes Mellitus: Implications of an Increased Frequency With IADPSG Criteria
Moses, R. G. (2012) · Diabetes Care · doi:10.2337/dc11-2237 · Cited by 27
“(6) in this issue has not necessarily widened the options but has merely reinforced that “one size does not fit all.”
InfluentialZhang, T., Wang, W., Huang, X., & Gao, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.664287 · Cited by 26
“Gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance with onset or first recognition during pregnancy, is now one of the most common complications of pregnancy affecting up to 9–26% of the obstetric population (1, 2).”
BackgroundMarschalek, J., Farr, A., Kiss, H., Hagmann, M., Göbl, C. S., Trofaier, M., Kueronya, V., & Petričević, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155182 · Cited by 26
“According to the International Association of Diabetes and Pregnancy Study Groups (IADPSG), GDM is diagnosed in case of at least one out of three (fasting, onehour, two-hours) elevated plasma glucose values [20].”
MethodKatra, P., Dereke, J., Nilsson, C., & Hillman, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155701 · Cited by 26
“8% in the HAPO patient material [11], an increase by almost 50% [12].”
BackgroundPostprandial interval walking—effect on blood glucose in pregnant women with gestational diabetes
Andersen, M. B., Fuglsang, J., Ostenfeld, E. B., Poulsen, C. W., Daugaard, M., & Ovesen, P. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100440 · Cited by 26
Hu, R., Liu, Z., Geng, Y., Huang, Y., Li, F., Dong, H., Ma, W., Song, K., Zhang, M., & Song, Y. (2023) · Microorganisms · doi:10.3390/microorganisms11071725 · Cited by 25
Mahdizade, A. H., Bahreiny, S. S., Bastani, M., Dabbagh, M. R., Aghaei, M., Malayeri, F. A., YousefiFard, A., & Taghizadeh, E. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01272-7 · Cited by 25
Gestational Diabetes. Obstetrical Perspective
Panaitescu, A. M., & Peltecu, G. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.331 · Cited by 25
Tantengco, O. A. G., Aquino, I. M. C., Asis, J. L. B., Tan, J. J. E., Uy, M. N. A. R., & Paz-Pacheco, E. T. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102202 · Cited by 24
PERFIL EPIDEMIOLÓGICO DE GESTANTES DIABÉTICAS NO MUNICÍPIO DE ITAJAÍ, SC
Bozatski, B. L., Pinto, M. F., & Lavado, M. M. (2019) · Arquivos Catarinenses de Medicina · doi:10.63845/q90e7141 · Cited by 24
Liu, B., Song, L., Zhang, L., Wang, L., Wu, M., Xu, S., Cao, Z., & Wang, Y. (2019) · Journal of Epidemiology · doi:10.2188/jea.je20180245 · Cited by 23
Cell-free nucleic acids in prenatal diagnosis and pregnancy-associated diseases.
Nagy, B. (2019) · PubMed · Cited by 23
Franzago, M., Fraticelli, F., Marchioni, M., Nicola, M. D., Sebastiano, F. D., Liberati, M., Stuppia, L., & Vitacolonna, E. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01668-5 · Cited by 24
Association Between Type of Screening for Gestational Diabetes Mellitus and Cesarean Delivery
Palatnik, A., Swanson, K., Churchill, T., Bilski, A., Grobman, W. A., & Miller, E. S. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002195 · Cited by 23
Saeedi, M., Hanson, U., Simmons, D. S., & Fadl, H. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1875-1 · Cited by 24
Kalok, A. H. M., Ong, M. Y., Hasrori, A., Chiang, K. S., Yazim, F., Baharuddin, S., Rahman, R. A., Shah, S. A., Aziz, N. H. A., Ahmad, S., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17196990 · Cited by 23
Bhavadharini, B., Anjana, R. M., Deepa, M., Pradeepa, R., Uma, R., Saravanan, P., & Mohan, V. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01815-6 · Cited by 23
“conducted secondary analysis of HAPO data and found that nearly 70% of women with GDM had a single abnormal value on the OGTT [18].”
MethodGlucose Intolerance after a Recent History of Gestational Diabetes
Benhalima, K., Leuridan, L., Calewaert, P., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/727652 · Cited by 23
“3% to >25% depending on the populations studied [4].”
Background
Metadata
- Authors
- Sacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., Persson, B., Trimble, E. R., & for the HAPO Study Cooperative Research Group
- Affiliations
- Kaiser Foundation Hospital (US)
- Royal Victoria Hospital (GB)
- St Mary's Hospital (GB)
- Rajavithi Hospital (TH)
- Northwestern University (US)
- Brown University (US)
- Tel Aviv University (IL)
- The University of Queensland (AU)
- Karolinska Institutet (SE)
- Queen's University Belfast (GB)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-02-10
- Volume
- 35
- Issue
- 3
- Pages
- 526-528
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3322716
- OpenAlex
- W2114819974
- Cited by
- 687
- References
- 6
- Citations by year
- 2026: 24 · 2025: 33 · 2024: 39 · 2023: 41 · 2022: 77 · 2021: 57 · 2020: 65 · 2019: 56 · 2018: 65 · 2017: 38 · 2016: 47 · 2015: 42 · 2014: 54 · 2013: 24 · 2012: 21
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- American Diabetes Association
- Kaiser Permanente
- Diabetes UK (RD04/ 0002756)
- Novo Nordisk
- National Institute of Diabetes and Digestive and Kidney Diseases (R01‐HD34243, R01-HD34242)
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- National Center for Research Resources (M01RR000080, M01 RR00048, M01RR00080, M01RR000048)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34242, 01-HD34243, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, IADPSG criteria, GDM prevalence, oral glucose tolerance test, diagnostic thresholds, HAPO study, fasting blood glucose, 2-hour plasma glucose
- MeSH terms
- Adult, Blood Glucose, Female, Glucose Tolerance Test, Humans, Hyperglycemia, Pregnancy, Diabetes, Gestational, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.